Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma
Adoptive cell therapy using TCR-engineered T cells (TCR-T cells) represents a promising strategy for treating relapsed and metastatic cancers. We previously established methods to identify neoantigen-specific TCRs based on patients’ PBMCs. However, in clinical practice isolation of PBMCs from advanc...
Main Authors: | Teng Wei, Matthias Leisegang, Ming Xia, Kazuma Kiyotani, Ning Li, Chenquan Zeng, Chunyan Deng, Jinxing Jiang, Makiko Harada, Nishant Agrawal, Liangping Li, Hui Qi, Yusuke Nakamura, Lili Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2021.1929726 |
Similar Items
-
Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
by: Lili Ren, et al.
Published: (2019-04-01) -
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
by: Daniel J. Verdon, et al.
Published: (2021-08-01) -
Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
by: Zhidong Wang, et al.
Published: (2020-03-01) -
Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies
by: Florian Kast, et al.
Published: (2021-01-01) -
The Ways of Isolating Neoantigen-Specific T Cells
by: Qing Li, et al.
Published: (2020-08-01)